Stephanie Cornyn
Vice President, Investor Relations, Communication and Commercial Strategy
Replay available
Innate Pharma S.A. (IPHA) Q3 2025 Earnings Call
Innate Pharma S.A. (NASDAQ: IPHA) Q3 2025 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jonathan Dickinson
Chief Executive Officer
Sonia Quarantino
Chief Medical Officer
Christopher Liu
Analyst, Lucid Capital Markets
Justin Zelen
Analyst, BTIG
Swan Pakula Ramakant
Analyst, HC Wingright
Diana Gray Bosch
Analyst, Learing Partners
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Innate Pharma Sa Class A.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.707 Ladies and gentlemen, thank you for joining us and welcome to the Innate Farmer third 00:00:04.707 -- 00:00:09.447 quarter 2025 business update and financial results. 00:00:09.447 -- 00:00:13.933 After today's prepared remarks, we will host a question and answer session. 00:00:13.933 -- 00:00:17.217 If you would like to ask a question, please raise your hand. 00:00:17.217 -- 00:00:21.884 If you have dialled into today's call, please press star nine to raise your hand and 00:00:21.884 -- 00:00:27.070 star six to unmute. I will now hand the conference over to Stephanie Cornyn, Vice 00:00:27.070 -- 00:00:32.598 President, Investor Relations, Communication and Commercial Strategy at N8 Pharma. 00:00:32.598 -- 00:00:35.579 Please go ahead. 00:00:36.430 -- 00:00:41.576 Good morning and good afternoon everyone. Thank you for joining us for INET Pharma Q3 00:00:41.576 -- 00:00:46.002 2025 Business Update and Financial Results Conference Call. 00:00:46.002 -- 00:00:51.048 The press release and today's presentation are both available on the IR section of 00:00:51.048 -- 00:00:53.211 our website. 00:00:53.211 -- 00:00:58.638 Before we begin, I'd like to remind everyone that today's presentation includes forward-looking 00:00:58.638 -- 00:01:01.743 statements based on current expectations. 00:01:01.743 -- 00:01:07.192 These statements involve risks and uncertainties that could cause actual results to differ 00:01:07.192 -- 00:01:09.192 materially. 00:01:10.163 -- 00:01:15.889 To begin, I briefly cover today's agenda. Our CEO, Jonathan Dickinson, 00:01:15.889 -- 00:01:19.533 will discuss our strategic priorities and pass forward. 00:01:19.533 -- 00:01:24.939 Then our CMO, Sonia Quarantino, will present clinical pipeline updates 00:01:24.939 -- ...